Nuclear Imaging

Siemens PETNET Solutions, 18F NaF, ANDA approval, PET radiopharmaceutical

Image courtesy of Siemens Healthcare

News | Radiopharmaceuticals and Tracers | October 02, 2015
Siemens’ PETNET Solutions has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug...
Celesteion PET/CT
News | PET-CT | October 01, 2015
October 1, 2015 — To advance clinical care for its customers, Toshiba’s Celesteion PET/CT system delivers a more comf
blood clot detection, single scan, rats, radionuclides, Peter Caravan, whole body

The whole body of a rat can be imaged for blood clots with one PET scan (which is overlaid here on an MRI image) using the FBP8 probe. Arrow points to a blood clot. Image courtesy of Peter Caravan, Ph.D.

News | PET Imaging | September 23, 2015
New research describes a method, tested in rats, that may someday allow healthcare providers to quickly scan the entire...
WMIS, WMIC 2015, MILabs, G-SPECT, Commerical Innovation of the Year, SPECT, PET, molecular imaging

G-SPECT photo courtesy of MILabs Inc.

News | SPECT Imaging | September 23, 2015
The World Molecular Imaging Society (WMIS) presented the first annual Commercial Innovation of the Year Award at the...
Dual-energy scanning

Dual-energy scanning, achieved on Siemens’ Definition Edge, reduces severe artifacts caused by an implanted pump (left), clearly visualizing surrounding anatomical structures (right). The twin-beam, single-source Edge is one of several platforms that can characterize tissues and structures according to the atomic numbers of their elements. (Image courtesy of Siemens Healthcare)

Blog | Computed Tomography (CT) | September 22, 2015
They were once the kings of computed tomography (CT) — 16-slice scanners that hinted at coronary CT angiography; 64 s
molecular imaging, imaging agent, GA-68 PSMA, improved detection, early recurrent, prostate cancer
News | Radiopharmaceuticals and Tracers | September 18, 2015
A recently developed drug was significantly better at detecting recurring prostate cancer in early stages, in research...
Novation, Mo-99, NNSA 2015 meeting, reliable supplies, domestic production
News | Radiopharmaceuticals and Tracers | September 17, 2015
At the National Nuclear Security Administration’s (NNSA) 2015 Mo-99 Topical Meeting, Novation offered its support of...
PET, imaging agent, hidden blood clots, MGH, radiopharmaceutical probe, 64Cu-FBP8
News | Radiopharmaceuticals and Tracers | September 16, 2015
A novel radiopharmaceutical probe developed at Massachusetts General Hospital (MGH) has the potential of providing...
ImaginAb, prostate imaging agent, prostate cancer, World Molecular Imaging Conference, molecular imaging, PET
News | Prostate Cancer | September 14, 2015
ImaginAb Inc. has released interim results from a Phase 2 clinical trial of IAB2M, the company's proprietary imaging...
Zevacor, IBA, 70 MeV cyclotron, Cyclone 70P, radiopharmaceuticals
News | Radiopharmaceuticals and Tracers | September 11, 2015
Zevacor Molecular (Zevacor), manufacturer and distributor of positron emission tomography (PET) and single photon...
News | Radiopharmaceuticals and Tracers | September 11, 2015
Westinghouse Electric Company and NorthStar Medical Radioisotopes announced a memorandum of understanding to explore...

Gout in the foot detected with the Somatom Force CT system’s dual energy, which could have otherwise been missed.

Feature | Imaging | September 08, 2015 | Jeff Zagoudis
Computed tomography (CT) has enjoyed a place of prominence in medical imaging since its creation in the 1970s.
Feature | AAPM | September 08, 2015 | Melinda Taschetta-Millane
During the recent American Association of Physicists in Medicine (AAPM) conference in Anaheim, Calif., I had the oppo
Navidea, SBIR grant, NCI, NIH, Kaposi's sarcoma, Tc99m tilmanocept, SPECT

Image courtesy of Navidea Biopharmaceuticals Inc.

News | Radiopharmaceuticals and Tracers | September 03, 2015
Navidea Biopharmaceuticals Inc. received initial notice of award for a Fast Track Small Business Innovation Research (...
NorthStar Medical Radioisotopes, approval, routine production, Molybdenum-99, Mo-99, University of Missouri Research Reactor, MURR
News | Radiopharmaceuticals and Tracers | August 31, 2015
NorthStar Medical Radioisotopes LLC has received approval to begin routine production of molybdenum-99 (Mo-99) at the...
News | Prostate Cancer | August 21, 2015
August 21, 2015 — A molecular imaging biomarker is able to detect fast-growing primary prostate cancer and distinguis
The ITM Group, in-licensing, DOTA-Zoledronate, theranostic agent, bone metastases, PET imaging
News | Radiopharmaceuticals and Tracers | August 20, 2015
The ITM Group announced that its subsidiary ITG GmbH has successfully in-licensed DOTA-Zoledronate, a next-generation...
Lymphoseek, Navidea, injection site pain, study, breast cancer patients, tracer
News | Radiopharmaceuticals and Tracers | August 20, 2015
August 20, 2015 — Navidea Biopharmaceuticals announced publication of the results from an investigator-initiated, com
IBA Molecular North America, IBAM NA, acquisition, Illinois Health and Science, IBA S.A.
News | Radiopharmaceuticals and Tracers | August 10, 2015
IBA (Ion Beam Applications S.A.) announced the completion of the divestiture of IBA Molecular North America Inc. (IBAM...
Alzheimer's Association, IDEAS Study, website, participation, brain PET scan
News | Neuro Imaging | August 05, 2015
August 5, 2015 — The Alzheimer’s Association announced the launch of a new website for the upcoming Imaging Dementia
Overlay Init